Amplifire and BioIntelliSense are pleased to announce a strategic collaboration to couple award-winning patient monitoring solutions and innovative, brain science-based clinical training to accelerate and scale continuous care models from in-hospital to home. BOULDER, Colo. and DENVER,…
News
Weekly Policy Blog: PDAB Releases Stakeholder Engagement Guide
As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs selected earlier this month, it is reaching out to stakeholders to request their engagement in the affordability review process […]
News
Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings
BOULDER, Colo., June 2, 2022 /PRNewswire/ — Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA, today announced it had […]
News
Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that members of the management team will hold a live webcast to discuss top-line data of EDG-7500 from the Phase […]
